Skip to main content

NUEVOS MECANISMOS DE LOS ENZIMAS BACTERIANOS DE LA SUPERFAMILIA ARQUEO/EUCARIOTA DE PRIMASAS EN LA REPARACION DE ROTURAS DE DNA Y EN LA ESCISION DE ELEMENTOS DE INSERCION

PID2020-115978GB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2020
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The enterohemorrhagic Escherichia coli insertion sequence-excision enhancer protein is a DNA polymerase with microhomology-mediated end-joining activity

  • Calvo, Patricia A.
  • Mateo-Cáceres, V.
  • Díaz-Arco, Silvia
  • Redrejo-Rodríguez, Modesto
  • Vega, Miguel de
Bacterial genomes contain an abundance of transposable insertion sequence (IS) elements that are essential for genome evolution and fitness. Among them, IS629 is present in most strains of enterohemorrhagic Escherichia coli O157 and accounts for many polymorphisms associated with gene inactivation and/or genomic deletions. The excision of IS629 from the genome is promoted by IS-excision enhancer (IEE) protein. Despite IEE has been identified in the most pathogenic serotypes of E. coli, its biochemical features that could explain its role in IS excision are not yet understood. We show that IEE is present in >30% of all available E. coli genome assemblies, and is highly conserved and very abundant within enterohemorrhagic, enteropathogenic and enterotoxigenic genomes. In vitro analysis of the recombinant protein from E. coli O157:H7 revealed the presence of a Mn2+-dependent error-prone DNA polymerase activity in its N-terminal archaeo-eukaryotic primase (AEP) domain able to promote dislocations of the primer and template strands. Importantly, IEE could efficiently perform in vitro an end-joining reaction of 3’-single-strand DNA overhangs with ≥4 bp of homology requiring both the N-terminal AEP and C-terminal helicase domains. The proposed role for IEE in the novel IS excision mechanism is discussed., MCIN/AEI/10.13039/501100011033 [PID2020-115978GB-I00 to M.V.]; MCIN/AEI/10.13039/501100011033/FEDER A way to make Europe [PID2021-123403NB-I00 to M.R.R.]; Comunidad de Madrid (V PRICIT call Research Grants for Young Researchers from Universidad Autónoma de Madrid) [SI3/PJI/2021-00271 to M.R.R.]; institutional grant from Fundación Ramón Areces to the Centro de Biología Molecular Severo Ochoa. Funding for open access charge: Consejo Superior de Investigaciones Científicas., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Darwinian Evolution of Self-Replicating DNA in a Synthetic Protocell

  • Abil, Zhanar
  • Restrepo Sierra, Ana María
  • Stan, Andreea R.
  • Châne, Amélie
  • Prado, Alicia del
  • Vega, Miguel de
  • Rondelez, Yannick
  • Danelon, Christophe
Replication, heredity, and evolution are characteristic of Life. We and others have postulated that the reconstruction of a synthetic living system in the laboratory will be contingent on the development of a genetic self-replicator capable of undergoing Darwinian evolution. Although DNA-based life dominates, the in vitro reconstitution of an evolving DNA self-replicator has remained challenging. We hereby emulate in liposome compartments the principles according to which life propagates information and evolves. Using two different experimental configurations supporting intermittent or semicontinuous evolution (i.e., with or without DNA extraction, PCR, and reencapsulation), we demonstrate sustainable replication of a linear DNA template¿encoding the DNA polymerase and terminal protein from the Phi29 bacteriophage ¿ expressed in the `protein synthesis using recombinant elements¿ (PURE) system. The self-replicator can survive across multiple rounds of replication-coupled transcription-translation reactions in liposomes and, within only ten evolution rounds, accumulates mutations conferring a selection advantage. Combined data from next-generation sequencing with reverse engineering of some of the enriched mutations reveal nontrivial and contextdependent effects of the introduced mutations. The present results are foundational to build up genetic complexity in an evolving synthetic cell, as well as to study evolutionary processes in a minimal cell-free system., The research was funded by the NWO Gravitation programs “BaSyC – Building a synthetic cell” (024.003.019) and “NanoFront – Frontiers of Nanoscience”. CD acknowledges funding from ANR (ANR-22-CPJ2-0091-01). ZA acknowledges funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement no. 707404. ARS acknowledges funding from a NanoFront-Casimir Research School PhD grant. MdV acknowledges funding by MCIN/AEI/10.13039/501100011033 (Grant PID2020-115978GB-I00)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Organocatalytic Switches of DNA Glycosylase OGG1 Catalyze a Highly Efficient AP-Lyase Function

  • Kehler, Mario
  • Zhou, Kaixin
  • Kemas, Aurino M.
  • del Prado, Alicia
  • Hutchinson, Emma Scaletti
  • Nairn, Elinor Hesslefors
  • Varga, Marek
  • Plattner, Yvonne
  • Zhong, Yi
  • Purewal-Sidhu, Oryn
  • Haslam, James
  • Wiita, Elisée
  • Gildie, Heather
  • Singerova, Karolina
  • Szaruga, Zuzanna
  • Almlöf, Ingrid
  • Hormann, Femke M.
  • Liu, Kang-Cheng
  • Wallner, Olov
  • Ortis, Florian
  • Homan, Evert J.
  • Gileadi, Opher
  • Rudd, Sean G.
  • Stenmark, Pål
  • de Vega, Miguel
  • Helleday, Thomas
  • D'Arcy-Evans, Nicholas D.
  • Lauschke, Volker M.
  • Michel, Maurice
8-oxoGuanine DNA glycosylase 1 (OGG1) is the first known target of organocatalytic switches (ORCAs), which rewrite the biochemical function of the enzyme through redirection of its preferred substrate from 8-oxoG to AP sites. Previously, different ORCA chemotypes were shown to enhance the operational pH window for OGG1, possibly through direct involvement in proton transfer events during DNA strand cleavage. Accordingly, compound pKa is a crucial and necessary consideration for the identification and application of future OGG1 ORCAs. Here, we identify a minimal structure of organocatalytic switches–4-anilino pyridines and 6-anilino pyrimidines–which are dimethyl-amino-pyridine (DMAP)-type Brønsted bases binding the active site of OGG1. Systematic interrogation of compound basicity through modulation of electron-withdrawing (EWG) and electron-donating (EDG) substituents reveals that a pKa less or equal to the assay pH is a viable parameter for prediction of compound activity. The lead structure (AC50 13 nM, pKa 7.0) was then identified as a potent scaffold from a screen in a patient-derived 3D model of metabolic dysfunction-associated steatohepatitis (MASH), where it reduced hepatic fibrosis by 35%. Collectively, these findings deepen the knowledge of this novel modulator class, with important implications for future enzyme targets and probe development., This work was funded by the Åke-Olsson foundation for haematological research (2020–00306 MM), the Helleday Foundation (OPS, FO), RSC BMCS Researcher Mobility Fellowship (MV), the Swedish Cancer Society (24 3848 Pj to PS, 24–0829-PT FMH, CAN2021/1490 to TH), a Novo Nordisk Pioneer Innovator Grant (NNF23OC0085944 MM), a Novo Nordisk Project Grant (NNF23OC0084420 VML), the Bengt Lundqvists Minne (JH), the Swedish Research Council (2021–02801, 2023–03015, 2024–03401 to VML, 021–06383 to TH, 2022–03681 to PS), European Research Council Proof of Concept grant SPHERO-NASH [Agreement no: 101123215] to VML, The Swedish Childhood Cancer Fund (PR2021-0030 OW), the Åke Wiberg Foundation (M23-0043 MM), Karolinska Institutet Research Foundation Grant (2022–01776 MM), Grant PID2020-115978GB-I00 (MdV) funded by MCIN/AEI/10.13039/501100011033. This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No. s (MM, EJH, EW, IA, OG, KCL, AMK, VML). The JU receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA and Ontario Institute for Cancer Research, Royal Institution for the Advancement of Learning McGill University, Kungliga Tekniska Högskolan, and Diamond Light Source Limited. This communication reflects the views of the authors, and the JU is not liable for any use that may be made of the information contained herein.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Nucleobase catalysts for the enzymatic activation of 8-oxoguanine DNA glycosylase 1

  • Hank, Emily C.
  • D’Arcy-Evans, Nicholas D.
  • Scaletti, Emma Rose
  • Benítez-Buelga, Carlos
  • Wallner, Olov
  • Ortis, Florian
  • Zhou, Kaixin
  • Meng, Liuzhen
  • del Prado, Alicia
  • Calvo, Patricia
  • Almlöf, Ingrid
  • Wiita, Elisée
  • Nierlin, Karen
  • Košenina, Sara
  • Krämer, Andreas
  • Eddershaw, Alice
  • Kehler, Mario
  • Long, Maeve
  • Jemth, Ann-Sofie
  • Dawson, Holly
  • Stewart, Josephine
  • Dickey, Adam
  • Astorga, Mikhael E.
  • Varga, Marek
  • Homan, Evert J.
  • Scobie, Martin
  • Knapp, Stefan
  • Sastre, Leandro
  • Stenmark, Pål
  • de Vega, Miguel
  • Helleday, Thomas
  • Michel, Maurice
Bifunctional DNA glycosylases employ an active site lysine or the N-terminus to form a Schiff base with an abasic (AP) site base excision repair intermediate. For 8-oxoguanine DNA glycosylase 1 (OGG1), cleaving this reversible structure is the rate-determining step in the initiation of 8-oxoguanine (8-oxoG) repair in DNA. Evolution has led OGG1 to use a product-assisted catalysis approach, where the excised 8-oxoG acts as a Brønsted base for cleavage of a Schiff base intermediate. However, the physicochemical properties of 8-oxoG significantly limit the inherent enzymatic turnover leading to a weak, cellularly absent, AP lyase activity. We hypothesized that chemical synthesis of purine analogues enables access to complex structures that are suitable as product-like catalysts. Herein, the nucleobase landscape is profiled for its potential to increase OGG1 Schiff base cleavage. 8-Substituted 6-thioguanines emerge as potent and selective scaffolds enabling OGG1 to cleave AP sites opposite any canonical nucleobase by b-elimination. This effectively broadens the enzymatic substrate scope of OGG1, shaping a complete, artificial AP-lyase function. In addition, a second class of compounds, 6-substituted pyrazolo-[3,4-d]-pyrimidines, stimulate OGG1 function at high pH, while thioguanines govern enzymatic control at acidic pH. This enables up to 20-fold increased enzyme turnover and a de novo OGG1 b-elimination in conditions commonly not tolerated. The tool compounds employed here are non-toxic in cells and stimulate the repair of AP sites through a natural, APE1 dependent pathway, as opposed to previously reported b,d-lyase stimulator TH10785., This work was funded by the Swedish Research Council (2018-03406 PS), the Alfred Österlund foundation (PS), the Crafoord foundation (20190532 PS), the Helleday Foundation (FO, LM), the Swedish Cancer Society (CAN2021/1490 TH), the Åke-Olsson foundation for haematological research (2020-00306 MM), a Novo Nordisk Pioneer Innovator Grant (NNF23OC0085944 MM), Karolinska Institutet Research Foundation Grants (2020-02186 and 2022-01776 MM), a Childhood Cancer Research Postdoctoral grant (ML), the Åke Wiberg Foundation (M23-0043 MM), Grant PID2020-115978GB-I00 (MdV) funded by MCIN/AEI/10.13039/501100011033, a Health Research Fund, Carlos III Health Institute, co-funded by European Regional Development (FEDER) funds (PI20-00335 LSG) and the Research Talent Attraction Grants (2023-T1/SAL-GL-29292 CBB). This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement no 875510 (MM, EJH, EW, IA, ASJ, AK, SKn, FO, KZ, MK, NDE). The JU receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA and Ontario Institute for Cancer Research, Royal Institution for the Advancement of Learning McGill University, Kungliga Tekniska Högskolan, Diamond Light Source Limited. This communication reflects the views of the authors and the JU is not liable for any use that may be made of the information contained herein. We would like to thank the Chemical Biology Consortium Sweden (CBCS), the Protein science facility (PSF) at Karolinska and the Structural Genomics Consortium (SGC) at Karolinska and Goethe-Universität Frankfurt for support. We are thankful to Athina Pliakou, Mari Kullman Magnusson, Kristina Edfeldt, Therese Pham, Opher Gileadi, and Michael Sundström for administrative support. We thank MAXIV Laboratory (Sweden, proposal MX20200204), Diamond Light Source (United Kingdom, proposals MX15806 and MX21625), and their scientists from the BioMAX and I03 beamlines for their support during data collection., Peer reviewed